Emilė RadytėIf you could save the economy £20.2bn — would you do it?51% of the British — and 56.3% of the American– workforce is women; and almost all of these employees will be in at least one of their…Nov 8, 2023Nov 8, 2023
Emilė RadytėI don’t have a problem with painkillers. Just with their side effectsPain killers have always put us in a frenzy — we’ve fought wars over opiates, charged the streets demanding regulation for opioids and…Oct 27, 2023Oct 27, 2023
Emilė RadytėWhy PMS, PMDD and hormone-related mental health is a serious clinical and scientific problemIt may be easy to overlook PMS (premenstrual syndrome) and PMDD (premenstrual dysphoric disorder) as just buzzwords or convenient labels…Oct 9, 20231Oct 9, 20231
Emilė RadytėTwo thoughts on why “women’s health” as a category is increasingly not helpfulOver the last few years, the number of companies being built to address women’s health needs has skyrocketed. There are now 763+ companies…Sep 25, 2023Sep 25, 2023
Emilė RadytėAre We OK Letting Diagnosis Alone Be The Treatment?We as a (Western) society have generally held three truths about how healthcare outcomes should be monitored and addressed in society.Jul 31, 2023Jul 31, 2023
Emilė RadytėWhy being a founder is probably harder for those trained in academiaP.S. My biased answer is at the end.Jul 24, 20231Jul 24, 20231
Emilė RadytėWomen will be the first adopters of neurotechnology — here’s whyTo your surprise and mine, women lining up to get the newest neurotech for their everyday needs didn’t seem to strike most of the people I…Jul 17, 2023Jul 17, 2023
Emilė Radytė7 Things We Learned About the Gender Pain Gap While Building a Neurotechnology CompanyAs co-founders of a neurotechnology company focused on women’s health, Samphire Neuroscience, Alex Cook and I embarked on a mission to…Jul 7, 20232Jul 7, 20232
